Shares outstanding decreased 1.0%
Shares outstanding changed -1.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -1.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Revenue changed +12.7% from the comparable as-filed period.
Free-cash-flow margin changed -313 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -72 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -99 basis points from the comparable as-filed period.
Operating cash-flow margin changed -273 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed +6046 basis points from the comparable as-filed period.
Receivables / revenue changed +607 basis points from the comparable as-filed period.
Capital expenditure changed +19.8% from the comparable as-filed period.
Operating income changed +6.6% from the comparable as-filed period.
Operating cash flow changed -3.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +21.7% from the comparable as-filed period.
Inventory / revenue changed +74 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +14.2% from the comparable as-filed period.
Capex / revenue changed +39 basis points from the comparable as-filed period.
Selling, general & administrative changed +9.1% from the comparable as-filed period.
Net income changed -5.8% from the comparable as-filed period.
SBC / revenue changed +6 basis points from the comparable as-filed period.
Operating cash flow / net income changed +2.4% from the comparable as-filed period.
Current assets changed -0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross margin changed -71 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +9.7% from the comparable as-filed period.
Inventory / revenue changed -176 basis points from the comparable as-filed period.
Debt / revenue changed +8275 basis points from the comparable as-filed period.
Operating margin changed -48 basis points from the comparable as-filed period.
Operating income changed +6.7% from the comparable as-filed period.
Trade receivables changed +12.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +3.9% from the comparable as-filed period.
Receivables / revenue changed +220 basis points from the comparable as-filed period.
Cost of revenue changed +11.1% from the comparable as-filed period.
Capex / revenue changed +5 basis points from the comparable as-filed period.
Free-cash-flow margin changed -97 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +0.9% from the comparable as-filed period.
Operating cash-flow margin changed -91 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +6.9% from the comparable as-filed period.
Capital expenditure changed +10.8% from the comparable as-filed period.
Net income changed +2.0% from the comparable as-filed period.
SBC / revenue changed -5 basis points from the comparable as-filed period.
Operating cash flow / net income changed +1.9% from the comparable as-filed period.
Stock-based compensation changed +3.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.